OrbiMed Advisors LLC's Form 4 filing
Q32 Bio Inc. (QTTB) · filed Jun 1, 2026
- Accession no.
- 0000947871-26-000593
- Filed
- Jun 1, 2026, 9:13 PM ET
- Trade date
- May 28, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $15.0M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | Director, 10% Owner |
| OrbiMed Capital GP VII LLCCIK 0001760648 | Director, 10% Owner |
| OrbiMed Genesis GP LLCCIK 0001808744 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 28, 2026 | Common Stock | PPurchaseAcquired | +1,250,000 | $8.00 | +$10,000,000 | 3,502,987 | Indirect | Duplicate filing |
| May 28, 2026 | Common Stock | PPurchaseAcquired | +625,000 | $8.00 | +$5,000,000 | 625,000 | Indirect | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.